sever
acut
respiratori
syndrom
sar
new
emerg
diseas
first
describ
patient
novemb
foshan
guangdong
provinc
southern
china
februari
world
health
organ
receiv
report
case
provinc
diseas
spread
rapidli
april
case
report
global
countri
four
contin
end
juli
sar
spread
countri
affect
peopl
result
almost
death
worldwid
took
econom
toll
least
billion
dollar
caus
microorgan
diseas
identifi
novel
coronaviru
diseas
transmit
droplet
direct
contact
although
airborn
oralfec
rout
transmiss
exclud
earli
case
sar
probabl
occur
southern
china
novemb
mani
case
sever
pneumonia
unknown
etiolog
guangdong
provinc
southern
china
high
rate
transmiss
health
care
worker
physician
southern
china
visit
hong
kong
februari
die
day
later
sever
pneumonia
thought
sourc
infect
caus
subsequ
outbreak
sar
hong
kong
vietnam
singapor
canada
index
patient
citi
expos
guangdong
physician
visit
china
stay
floor
hotel
may
patient
hong
kong
sar
health
care
worker
two
hundr
fiftyf
patient
die
period
sar
appear
spread
close
persontoperson
contact
droplet
transmiss
fomit
high
level
infect
viral
ill
highlight
fact
patient
hospit
sar
within
week
result
exposur
one
patient
gener
medic
ward
hong
kong
use
jet
nebul
administ
bronchodil
index
case
present
clinic
communityacquir
pneumonia
could
increas
droplet
load
around
patient
overcrowd
condit
hospit
ward
contribut
major
hospit
outbreak
coronavirus
larg
envelop
virus
positivesens
rna
genom
rang
size
kb
clinic
speak
coronavirus
usual
associ
common
cold
human
anim
viru
caus
highli
virul
respiratori
enter
neurolog
diseas
hepat
detect
viru
sputum
fece
indic
one
tissu
tropism
protean
clinic
present
full
sequenc
sar
coronaviru
sarscov
recent
report
canadian
collabor
group
base
genom
denot
possess
classic
coronaviru
complement
openread
frame
spike
membran
small
envelop
e
glycoprotein
matrix
replicas
nucleocapsid
n
protein
howev
amino
acid
level
sarscov
minimum
homolog
three
class
coronaviru
thu
sarscov
group
separ
studi
compar
fulllength
genom
sequenc
analysi
sarscov
isol
remark
genet
conserv
viru
found
sinc
outbreak
first
document
februari
sever
acut
respiratori
syndrom
sar
highli
contagi
predominantli
pneumon
ill
caus
novel
coronaviru
commonli
known
sarscov
articl
describ
key
diagnost
clinic
featur
radiolog
featur
investig
profil
affect
patient
summar
understand
anecdot
experi
limit
publish
data
use
antivir
corticosteroid
therapi
manag
highli
contagi
diseas
furthermor
viru
sequenc
patient
massiv
diarrhea
show
nucleotid
differ
compar
earlier
patient
respiratori
symptom
thu
alter
sarscov
genom
unlik
caus
distinct
clinic
featur
syndrom
appar
genet
stabil
make
vaccin
seem
achiev
year
sarscovlik
virus
isol
himalayan
palm
civet
found
liveanim
market
guangdong
evid
viral
infect
also
detect
anim
includ
raccoon
dog
nyctereut
procyonoid
rat
human
work
market
anim
isol
retain
sequenc
found
human
isol
detect
sarscovlik
virus
small
live
wild
mammal
retail
market
indic
rout
interspeci
transmiss
although
natur
reservoir
unknown
patient
sar
initi
present
fever
c
hour
chill
approxim
patient
also
complain
nonproduct
cough
dyspnea
malais
headach
diagnosi
patient
report
upper
respiratori
tract
symptom
rhinorrhea
nasal
obstruct
sneez
sore
throat
hoars
usual
interv
day
onset
fever
experienc
dyspnea
physic
examin
chest
usual
normal
initi
sign
consolid
includ
crackl
dull
percuss
occur
later
stage
diseas
wateri
diarrhea
report
subgroup
patient
week
clinic
cours
report
cohort
infect
commun
outbreak
link
faulti
sewag
system
presum
caus
involv
gastrointestin
tract
fecalor
rout
howev
also
possibl
diarrhea
could
secondari
antibiot
therapi
patient
wherea
leukocytosi
leukopenia
thrombocytopenia
uncommon
lymphopenia
cellsmm
almost
alway
seen
diseas
onset
lymphopenia
caus
destruct
lymphocyt
transaminas
includ
aspart
aminotransferas
ast
alanin
aminotransferas
alt
elev
slightli
patient
tend
normal
simultan
clinic
radiolog
recoveri
featur
lowgrad
dissemin
intravascular
coagul
ie
thrombocytopenia
prolong
activ
partial
thromboplastin
time
elev
ddimer
level
elev
lactat
dehydrogenas
level
reflect
lung
injuri
creatinin
kinas
level
reflect
myositi
common
laboratori
featur
sar
renal
function
reflect
serum
creatinin
level
usual
normal
admiss
howev
lateonset
acut
renal
failur
occur
patient
recent
retrospect
analysi
patient
sar
patholog
pictur
sar
appear
follow
triphas
pattern
sever
case
phase
viremia
viral
replic
associ
increas
viral
load
clinic
character
fever
myalgia
system
symptom
gener
improv
day
phase
immunopatholog
damag
character
recurr
fever
oxygen
desatur
radiolog
progress
pneumonia
decreas
viral
load
patient
respond
treatment
combin
antivir
agent
steroid
patient
may
progress
phase
character
acut
respiratori
distress
syndrom
ard
necessit
ventilatori
support
sar
seem
run
less
aggress
clinic
cours
younger
children
adult
teenag
children
case
studi
requir
supplementari
oxygen
radiograph
appear
sar
share
featur
caus
pneumonia
fever
onset
almost
patient
sar
abnorm
chest
radiograph
show
airspac
consolid
patient
eventu
develop
airway
opac
cours
diseas
opac
occupi
peripher
mix
peripher
axial
locat
patient
predomin
involv
lung
peripheri
lower
zone
addit
absenc
cavit
hilar
lymphadenopathi
pleural
effus
diagnosi
distinct
radiograph
featur
sar
radiograph
progress
unilater
focal
airspac
opac
multifoc
bilater
involv
second
week
diseas
cours
follow
radiograph
improv
treatment
commonli
encount
radiolog
appear
sar
describ
similar
bronchiol
obliteran
organ
pneumonia
includ
periph
r
l
p
p
e
r
n
c
e
f
l
u
n
g
p
c
e
l
owe
r
l
b
e
predomin
mixtur
groundglass
opac
consolid
fig
contrari
bronchiolitisorgan
pneumonia
lymphadenopathi
pleural
effus
sar
one
report
patient
develop
spontan
pneumomediastinum
patient
develop
evid
ard
period
week
gener
incid
barotrauma
intens
care
unit
icu
admiss
seem
higher
expect
despit
treatment
lowvolum
lowpressur
mechan
ventil
yet
excess
hyperinfl
bullou
lung
diseas
commonli
encount
studi
quantifi
sever
lung
abnorm
chest
radiograph
correl
clinic
laboratori
paramet
signific
relationship
among
radiograph
paramet
oxygen
supplement
treatment
respons
highresolut
comput
tomographi
ct
scan
thorax
use
detect
lung
opac
patient
unremark
chest
radiograph
find
fig
common
find
includ
groundglass
opacif
sometim
consolid
interlobular
septal
intralobular
interstiti
thicken
fig
predominantli
peripher
lower
lobe
involv
characterist
peripher
alveolar
opac
similar
found
patient
bronchiol
obliteransorgan
pneumonia
best
character
ct
scan
daili
radiograph
assess
essenti
monitor
potenti
rapidli
progress
pneumon
ill
invas
procedur
bronchoscopi
associ
specimen
collect
impos
prohibitori
high
infect
risk
oper
initi
radiograph
might
normal
rapid
progress
groundglass
opacif
sometim
even
overnight
despit
potent
antibiot
therapi
probabl
help
diagnost
clue
airspac
opacif
often
progress
size
extent
sever
within
day
sever
case
diffus
opacif
suggest
ard
develop
despit
intens
treatment
rare
nodul
dissimilar
seen
miliari
tuberculosi
also
appear
background
groundglass
opacif
necessit
invas
investig
transbronchi
biopsi
milari
tuberculosi
fungal
infect
exclud
particularli
import
later
stage
diseas
patient
might
develop
secondari
infect
lung
receiv
consider
dose
corticosteroid
initi
diagnosi
sar
base
clinic
epidemiolog
laboratori
criteria
outlin
us
center
diseas
control
prevent
cdc
clinic
criteria
includ
asymptomat
mild
respiratori
ill
moder
respiratori
ill
ie
temperatur
f
c
least
one
respiratori
featur
ie
cough
dyspnea
difficulti
breath
hypoxia
sever
respiratori
ill
featur
second
criterion
radiograph
evid
pneumonia
presenc
respiratori
distress
syndrom
autopsi
find
consist
pneumonia
presenc
respiratori
distress
syndrom
without
identifi
caus
epidemiolog
criteria
includ
travel
includ
transit
airport
within
day
onset
symptom
area
current
recent
document
suspect
commun
transmiss
sar
close
contact
within
day
onset
symptom
person
known
suspect
sar
infect
laboratori
criteria
includ
detect
antibodi
sarscov
specimen
obtain
acut
ill
day
ill
onset
detect
sarscov
rna
revers
transcriptas
polymeras
chain
reaction
rtpcr
confirm
second
pcr
assay
use
second
aliquot
specimen
differ
set
pcr
primer
isol
sarscov
sinc
last
case
sar
infect
juli
epidemiolog
criterion
travel
may
applic
case
definit
propos
cdc
design
toward
diseas
surveil
make
bedsid
clinic
diagnosi
sar
despit
avail
sever
rtpcr
techniqu
sinc
march
remain
valid
molecular
assay
current
avail
detect
sarscov
low
sensit
specif
earli
stage
ill
recent
combin
modifi
rna
extract
method
realtim
quantit
pcr
technolog
one
laboratori
report
posit
detect
rate
sampl
nasopharyng
aspir
sampl
realtim
rtpcr
assay
although
sensit
might
seem
accept
high
highli
signific
proport
patient
would
miss
test
use
lone
diagnost
criterion
commonli
perhap
erron
perceiv
specif
rtpcr
assay
also
unknown
thu
make
test
unqualifi
gold
standard
diagnost
test
find
must
valid
laboratori
larger
sampl
number
serolog
test
detect
specif
immunoglobul
sarscov
specif
take
day
patient
show
signific
increas
fourfold
titer
help
establish
diagnosi
earli
key
phase
outbreak
sensit
specif
sar
serolog
test
also
unknown
period
sarscov
infect
confirm
molecular
serolog
test
summar
tabl
even
patholog
find
sarsrel
ard
readili
recogniz
autopsi
openlung
biopsi
diffus
alveolar
damag
still
regard
nonspecif
although
recent
establish
diagnost
criteria
cdc
requir
laboratori
proof
sarscov
infect
rtpcr
detect
sarscov
serolog
proof
signific
increas
specif
antibodi
titer
posit
viral
cultur
yield
sarscov
diagnos
sar
process
larg
remain
clinic
decis
diagnost
process
usual
made
care
repeatedli
review
clinic
featur
radiolog
find
hematolog
biochem
profil
patient
importantli
diagnosi
made
consider
effort
made
exclud
background
pneumonia
especi
caus
atyp
organ
eg
mycoplasma
pneumonia
chlamydia
pneumonia
legionella
pneumophila
mimick
diseas
especi
bronchiolitisorgan
pneumonia
consid
resurg
sar
five
prerequisit
diagnosi
confirm
sar
clinic
symptom
respiratori
ill
temperatur
c
least
one
respiratori
featur
cough
dyspnea
difficulti
breath
hypoxia
presenc
radiolog
evid
consolid
failur
demonstr
clinic
radiolog
respons
potent
antibiot
therapi
otherwis
unexplain
persist
abnorm
lymphopenia
increas
ast
alt
molecular
serolog
confirm
sarscov
infect
histori
contact
suspect
confirm
patient
sar
histori
travel
atrisk
area
also
help
sar
suspect
patient
must
admit
design
isol
ward
wait
confirm
sarscov
infect
proper
isol
mandatori
prevent
crossinfect
within
hospit
diseas
transmit
droplet
direct
contact
outbreak
hospit
health
care
institut
result
commun
outbreak
must
prevent
stringent
infect
control
strategi
ward
design
triag
ie
initi
admiss
suspect
confirm
sar
step
ie
nonsar
triag
suspect
confirm
sar
ward
isol
singleor
doubleb
ward
neg
pressur
doubledoor
facil
bed
separ
next
feet
air
exchang
rate
time
per
hour
temperatur
c
maintain
ward
patient
requir
wear
surgic
mask
time
except
meal
visit
famili
friend
permit
staff
enter
ward
requir
follow
strict
stepwis
gown
degown
procedur
standard
person
protect
equip
includ
dispos
surgic
paper
cap
mask
reusabl
eye
goggl
reusabl
green
cotton
necktoheel
surgic
gown
glove
clear
plastic
face
shield
worn
patient
care
specimen
collect
procedur
must
immedi
dispos
afterward
adopt
frequent
effect
handwash
use
dilut
bleach
wipe
work
surfac
floor
essenti
use
nebul
therapi
consid
caus
major
hospit
outbreak
hong
kong
thu
avoid
patient
suspect
probabl
sar
initi
treatment
patient
sar
start
use
potent
antibiot
target
bacteri
pathogen
incrimin
etiolog
sever
communityacquir
pneumonia
usual
includ
combin
intraven
cefepim
g
three
time
daili
oral
clarithromycin
mg
two
time
daili
intraven
levofloxacin
mgday
event
allergi
patient
nonsar
communityacquir
pneumonia
would
radiolog
resolut
resolut
fever
even
partial
diagnosi
sar
patient
could
effect
exclud
although
monitor
least
day
hospit
isol
initi
home
quarantin
later
typic
case
sar
high
fever
lymphopenia
astalt
abnorm
usual
persist
radiograph
deterior
without
highresolut
ct
evid
widespread
chang
sar
crisi
march
june
patient
would
consid
empir
antisar
therapi
usual
administ
day
hospit
often
difficulti
indol
case
neither
progress
improv
clinic
radiolog
within
first
day
admiss
particularli
epidemiolog
link
explicit
anecdot
experi
use
combin
ribavirin
steroid
describ
three
studi
hong
kong
ribavirin
g
three
time
daili
oral
mg
everi
hour
intraven
corticosteroid
prednisolon
mgkg
per
day
prescrib
combin
specif
antisar
radiolog
progress
pneumonia
andor
hypoxemia
case
intraven
highdos
methylprednisolon
g
daili
dose
administ
prevent
immunopatholog
lung
injuri
rational
progress
pulmonari
diseas
may
mediat
host
inflammatori
respons
patient
appear
favor
respons
combin
treatment
resolut
fever
lung
opac
within
week
wherea
approxim
cohort
requir
icu
admiss
requir
invas
ventilatori
support
howev
use
ribavirin
therapi
patient
sar
associ
signific
toxic
includ
hemolysi
patient
decreas
hemoglobin
gdl
patient
elev
transaminas
level
patient
bradycardia
patient
reserv
ribavirin
exhibit
vitro
efficaci
sarscov
rais
question
whether
improv
could
caus
immun
defens
patient
rather
antivir
effect
ribavirin
anoth
drawback
earli
introduct
corticosteroid
possibl
link
use
avascular
necrosi
bone
detect
least
patient
routin
magnet
reson
imag
scan
criteria
unpublish
data
better
understand
pathogenesi
ration
test
antivir
agent
earli
virem
phase
establish
sar
spare
initi
use
corticosteroid
one
promis
agent
kaletra
lopinavirritonavir
abbott
laboratori
abbott
park
il
antiproteas
design
hiv
recent
retrospect
analysi
patient
hong
kong
shown
addit
kaletra
initi
treatment
associ
signific
reduct
overal
death
rate
intub
rate
compar
match
cohort
receiv
aforement
standard
treatment
respect
lower
rate
use
methylprednisolon
rescu
therapi
lower
mean
dose
howev
subgroup
receiv
kaletra
rescu
therapi
show
differ
overal
death
rate
rate
oxygen
desatur
vitro
studi
reveal
lopinavir
exhibit
vitro
activ
prototyp
sarscov
act
synerg
ribavirin
yet
toxic
ribavirin
treatment
regimen
sar
need
test
random
placebocontrol
design
potenti
therapeut
agent
base
sole
vitro
studi
thu
less
clinic
basi
use
prefer
firstlin
therapi
immunopatholog
damag
lung
phase
ard
phase
appear
mediat
enhanc
immun
respons
result
inflammatori
injuri
sar
immunomodul
therapi
logic
treatment
experiment
sarsrel
ard
character
pulmonari
infiltr
macrophag
releas
macrophag
migrat
inhibitori
factor
mif
final
caus
sever
alveolar
damag
experiment
acut
lung
injuri
ard
effect
amelior
corticosteroid
antimif
treatment
thu
use
corticosteroid
phase
sar
infect
appropri
therapeut
approach
base
anim
studi
ard
recent
studi
shown
superior
puls
steroid
nonpuls
steroid
treatment
sarsinduc
ard
despit
similar
cumul
steroid
dosag
icu
admiss
mechan
ventil
hematolog
biochem
paramet
group
day
patient
puls
steroid
group
less
oxygen
requir
better
radiograph
outcom
less
likelihood
requir
rescueaddit
puls
steroid
therapi
counterpart
thu
initi
use
puls
methylprednisolon
therapi
appear
efficaci
equal
safe
steroid
regimen
compar
regimen
lower
dosag
consid
prefer
steroid
regimen
treatment
sar
pend
data
futur
random
control
trial
antimif
therapi
effect
amelior
pulmonari
injuri
experiment
ard
model
suppli
limit
clinic
use
human
mif
induc
tumor
necrosi
factor
tnf
product
macrophag
amplifi
proinflammatori
loop
use
avail
commerci
also
may
consid
adjuv
immunomodulatori
agent
demonstr
patholog
condit
convalesc
serum
patient
recov
sar
suggest
altern
immunomodulatori
treatment
nevertheless
use
limit
suppli
serum
donor
risk
viral
infect
may
even
aggrav
antibodydepend
enhanc
calcul
case
fatal
rate
situat
emerg
epidem
difficult
estim
recent
onset
sar
epidem
worldwid
research
develop
diagnost
test
effect
treatment
urgent
need
hope
avail
genom
sequenc
sarscov
facilit
effort
develop
new
rapid
diagnost
test
antivir
agent
vaccin
sar
patient
recov
acut
ill
monitor
care
possibl
continu
viral
shed
potenti
develop
pulmonari
fibrosi
longterm
complic
prevent
spread
ill
import
highli
infecti
diseas
isol
facil
strict
precaut
droplet
exposur
among
health
care
worker
manag
patient
sar
avoid
use
nebul
gener
medic
ward
contact
trace
quarantin
isol
close
contact
import
measur
